Early Initiation of Tocilizumab Treatment Against Moderate-to-Severe Myelitis in Neuromyelitis Optica Spectrum Disorder

BACKGROUND: Interleukin-6 receptor blockade is effective in reducing the risk of relapses in neuromyelitis optica spectrum disorder (NMOSD). However, its efficacy during acute attacks of NMOSD remains elusive. OBJECTIVE: We investigated the effects of tocilizumab on disability during acute attacks,...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Chen, Zeng, Pei, Han, Jin-Rui, Zhang, Tian-Xiang, Jia, Dongmei, Shi, Fu-Dong, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566740/
https://www.ncbi.nlm.nih.gov/pubmed/34745082
http://dx.doi.org/10.3389/fimmu.2021.660230

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8566740/
https://www.ncbi.nlm.nih.gov/pubmed/34745082
http://dx.doi.org/10.3389/fimmu.2021.660230

Ejemplares similares